Andrews, Robert K.

Bcl-xL–inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets

Schoenwaelder, S. M., Jarman, K. E., Gardiner, E. E., Hua, M., Qiao, J., White, M. J., Josefsson, E. C., Alwis, I., Ono, A., Willcox, A., et al. (2011) · Blood

Platelet Disorders and TreatmentsBlood Coagulation and Thrombosis Mechanisms

Cited by 351

Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta.

Krozowski, Z., MaGuire, J. A., Stein-Oakley, A. N., Dowling, J., Smith, R. E., & Andrews, R. K. (1995) · The Journal of Clinical Endocrinology & Metabolism

Hormonal Regulation and HypertensionEstrogen and related hormone effects

Cited by 252

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

Flierl, U., Nero, T. L., Lim, B., Arthur, J. F., Yao, Y., Jung, S. M., Gitz, E., Pollitt, A. Y., Zaldivia, M. T. K., Jandrot-Perrus, M., et al. (2015) · Journal of Experimental Medicine

Platelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and Thrombosis

Cited by 114

Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G

Gardiner, E. E., De Luca, M., McNally, T., Michelson, A. D., Andrews, R. K., & Berndt, M. C. (2001) · Blood

Cell Adhesion Molecules ResearchNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 72